Leadership

A team with deep MedTech and clinical expertise across APAC.

Eve is led by operators with 15+ years of reproductive-technology commercial experience, regulatory acumen, and region-wide networks — founders who have built fertility markets and shipped medical devices across Asia-Pacific.

Built by operators who built the region

The founding team brings 15 years of regional MedTech experience, including fertility-technology partnerships across Malaysia, Singapore, Indonesia, Thailand and China. APAC is not a new market for us — decentralized embryo culture is.

Yve Lyppens
Founder & CEO
Yve Lyppens
Yve Lyppens is the Founder & CEO of Eve Fertility. He brings 15 years of MedTech commercial experience across Asia-Pacific, including leading APAC market development for a Nasdaq-listed fertility technology company where he built distributor networks and hospital partnerships across 12 markets. He founded Eve in 2024 to decentralize access to fertility care — translating deep regional market knowledge into a deployable platform for secondary-city hospitals. Yve completed executive education in Healthcare Management & Policy through HEC Paris, held at Weill Cornell in New York. He is based in Hong Kong.
R Reuters: China IVF policy (2023)
Col. Dr. Othman Sukhilmi
Co-Founder & Director of Medical Affairs
Col. Dr. Othman Sukhilmi
Dr. Sukhilmi Bin Othman is a Consultant Obstetrician and Gynaecologist who served 17 years in the Malaysian Armed Forces, delivering care in both rural and urban settings for economically disadvantaged patients. Following his retirement, he established and has operated his own Maternity Hospital in Senawang for the past decade. He pioneered office-based tubal patency testing (HyFoSy) in Malaysia in 2015, and co-authored the first intravaginal culture (IVC) study in Malaysia and APAC in 2022 — making fertility treatment accessible to lower-income patients. He holds a Master in Obstetrics & Gynaecology and an M.D. from the National University of Malaysia (UKM).

Deep roots in MedTech and fertility.

Commercial

$30M+ in partnerships

Yve has negotiated and managed distribution and licensing agreements totalling $30M+ in direct sales and recurring revenue across APAC.

Regulatory

Multi-jurisdiction approval

Yve and Othman have successfully navigated regulatory approval and market entry across Malaysia, Singapore, China, Indonesia and Thailand.

Clinical

Embedded in fertility networks

The team has established working relationships with major fertility operators, hospital systems and clinicians across the region.

Get in touch

Contact the team.

Questions about Eve, EVEA™, or partnership opportunities — reach out.

Contact us →